Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Regular aspirin use does not reduce risk of cognitive decline.

Kelley BJ, McClure LA, Unverzagt FW, Kissela B, Kleindorfer D, Howard G, Wadley VG.

J Am Geriatr Soc. 2015 Feb;63(2):390-2. doi: 10.1111/jgs.13271. No abstract available.

2.

Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population.

Mandas A, Mereu RM, Catte O, Saba A, Serchisu L, Costaggiu D, Peiretti E, Caminiti G, Vinci M, Casu M, Piludu S, Fossarello M, Manconi PE, Dessí S.

Front Aging Neurosci. 2014 Nov 7;6:309. doi: 10.3389/fnagi.2014.00309. eCollection 2014.

3.

Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up Study.

ADAPT-FS Research Group.

Alzheimers Dement. 2015 Feb;11(2):216-25.e1. doi: 10.1016/j.jalz.2014.03.009. Epub 2014 Jul 9.

4.

Inflammatory process in Alzheimer's Disease.

Meraz-Ríos MA, Toral-Rios D, Franco-Bocanegra D, Villeda-Hernández J, Campos-Peña V.

Front Integr Neurosci. 2013 Aug 13;7:59. doi: 10.3389/fnint.2013.00059. eCollection 2013.

5.

Inhibition of microglia activation as a phenotypic assay in early drug discovery.

Figuera-Losada M, Rojas C, Slusher BS.

J Biomol Screen. 2014 Jan;19(1):17-31. doi: 10.1177/1087057113499406. Epub 2013 Aug 14. Review.

6.

Effects of Peripheral and Intra-hippocampal Administration of Sodium Salicylate on Spatial Learning and Memory of Rats.

Azimi L, Pourmotabbed A, Ghadami MR, Nedaei SE, Pourmotabbed T.

Iran J Basic Med Sci. 2012 Mar;15(2):709-18.

7.

Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women.

Kern S, Skoog I, Ostling S, Kern J, Börjesson-Hanson A.

BMJ Open. 2012 Oct 3;2(5). pii: e001288. doi: 10.1136/bmjopen-2012-001288. Print 2012.

8.

NSAIDs may protect against age-related brain atrophy.

Bendlin BB, Newman LM, Ries ML, Puglielli L, Carlsson CM, Sager MA, Rowley HA, Gallagher CL, Willette AA, Alexander AL, Asthana S, Johnson SC.

Front Aging Neurosci. 2010 Sep 3;2. pii: 35. doi: 10.3389/fnagi.2010.00035. eCollection 2010.

9.

Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.

Crane PK, Narasimhalu K, Gibbons LE, Mungas DM, Haneuse S, Larson EB, Kuller L, Hall K, van Belle G.

J Clin Epidemiol. 2008 Oct;61(10):1018-27.e9. doi: 10.1016/j.jclinepi.2007.11.011. Epub 2008 May 5. Review.

10.

Anti-inflammatory agents and cognitive decline in a bi-racial population.

Grodstein F, Skarupski KA, Bienias JL, Wilson RS, Bennett DA, Evans DA.

Neuroepidemiology. 2008;30(1):45-50. doi: 10.1159/000115749. Epub 2008 Feb 7.

11.

Too little, too late?

Prettyman RJ.

BMJ. 2007 May 26;334(7603):1071. No abstract available.

12.

Low dose aspirin and cognitive function in the women's health study cognitive cohort.

Kang JH, Cook N, Manson J, Buring JE, Grodstein F.

BMJ. 2007 May 12;334(7601):987. Epub 2007 Apr 27.

13.

Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications.

Hernández-Díaz S, García Rodríguez LA.

BMC Med. 2006 Sep 20;4:22.

Supplemental Content

Support Center